Study of Brentuximab Vedotin (SGN-35) in Pediatric Patients With Relapsed or Refractory Systemic Anaplastic Large-Cell Lymphoma or Hodgkin Lymphoma
 
Sponsors and Collaborators
Millennium Pharmaceuticals, Inc.
 
Contact
Millennium Medical and Drug Information Center
1-877-674-3784
 
Investigator
Medical Monitor
Millennium Pharmaceuticals, Inc.
 
ClinicalTrials.gov Identifier